Bicara Therapeutics Inc (BCAX) returns
$9.13 -6.17% Close Oct 30, 2026 Live
Bicara Therapeutics returns over 1 year
$1,000 invested in Bicara Therapeutics one year ago was worth $554.68 at the close on October 30, 2026, with dividends reinvested. The same $1,000 in the S&P 500 (SPY) became $1,124.
BCAX, $10,000 investedS&P 500 (SPY)
$5,000$10,000
20252026
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | -50.9% | — | $490.60 | -0.9% |
| 3 months | -65.2% | — | $347.55 | +2.1% |
| Year to date | -45.8% | — | $542.48 | +11.7% |
| 1 year | -44.5% | — | $554.68 | +12.4% |
Bicara Therapeutics return by calendar year
| Year | BCAX | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | -45.8% | +11.7% | -57.4% |
| 2025 | -3.4% | +17.7% | -21.1% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also:
No forecast, no recommendation. This page describes Bicara Therapeutics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.